Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia
Background: An increase in candidemia has been observed throughout the world since the start of the COVID-19 pandemic. Patients with COVID-19 may have different risk factors, clinical presentations, and outcomes compared to patients without COVID-19. Methods: We conducted a retrospective chart revie...
Main Authors: | Nora Colburn, Courtney Nichols, Mark Lustberg, Shandra Day, Michael Haden, Christina Liscynesky |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-07-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X22002042/type/journal_article |
Similar Items
-
Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era
by: Christina Routsi, et al.
Published: (2022-06-01) -
The treatment of candidemia.
by: Tang, C, et al.
Published: (1995) -
Zoster on the brain: Clinical characteristics of patients PCR positive for varicella-zoster virus in cerebrospinal fluid and implications for transmission base
by: Mahmoud Al-Saadi, et al.
Published: (2022-07-01) -
Candidemia en Colombia
by: Jorge Alberto Cortés, et al.
Published: (2020-03-01) -
Effect of statin use on outcomes of adults with candidemia.
by: Guillermo Cuervo, et al.
Published: (2013-01-01)